Acquisition of Paclitaxel Medication for Exclusive Supply from Moonsurge Laboratory: Year 2026
About This Opportunity
TranslatedThis tender pertains to the acquisition of Paclitaxel medication, which is to be supplied exclusively by Moonsurge Laboratory for the year 2026. Paclitaxel is a critical chemotherapeutic agent used in the treatment of various cancers, and its procurement is essential for ensuring the availability of this medication in healthcare facilities. The tender outlines the specific requirements for the medication, including quality standards, packaging, and delivery timelines. Interested suppliers must demonstrate their capacity to meet these requirements and provide evidence of compliance with relevant health regulations. The location for the delivery of the medication will be specified in the tender documents, which will also detail the submission process for bids. This procurement is crucial for maintaining the continuity of cancer treatment programs and ensuring that patients have access to necessary medications. Suppliers are encouraged to review the tender documents thoroughly to understand the scope of work and any additional criteria that may be required for participation. The deadline for submission of proposals will be indicated in the official tender announcement.
This is a supplies contract in the health and medical services, trade and industry and transport and logistics sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 16,800.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender invites proposals for the exclusive procurement of Paclitaxel, a critical chemotherapeutic agent, to be supplied by the Laboratory Moonsurge for the year 2026. The tender is issued within the framework of public contracts in Portugal, specifically aimed at ensuring the availability of this essential medication for cancer treatment across the country.
Paclitaxel is widely recognized for its effectiveness in treating various types of cancer, including breast, ovarian, and lung cancers. The contracting authority is seeking a reliable supplier capable of meeting specific quality standards and regulatory compliance associated with pharmaceutical products.
Proposals must demonstrate adherence to Good Manufacturing Practices (GMP) and relevant European Medicines Agency (EMA) regulations to ensure the safety and efficacy of the medication provided.
Bidders are expected to outline their supply chain capabilities, including logistics, storage, and distribution processes, ensuring that the product can be delivered promptly and efficiently throughout Portugal. Additionally, potential suppliers should provide evidence of previous experience in supplying similar pharmaceutical products to public health systems or large healthcare institutions.
The tender emphasizes transparency and fairness in the procurement process, encouraging participation from qualified suppliers capable of providing a consistent and high-quality product. Interested parties should submit their proposals through the designated platform, ensuring compliance with all outlined requirements and deadlines. This initiative highlights Portugal's commitment to enhancing healthcare accessibility and quality through strategic procurement practices.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 19, 2026. Last refreshed 10 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About UNIDADE LOCAL DE SAÚDE DA GUARDA, E.P.E
UNIDADE LOCAL DE SAÚDE DA GUARDA, E.P.E has issued 301 procurement notices on BidsFactory, including 0 currently open and 296 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 5, 2026.
Frequently asked questions about this tender
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €16,800. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to MOONSURGE CIRURGIA E INOVAÇÃO. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by UNIDADE LOCAL DE SAÚDE DA GUARDA, E.P.E in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.